BIOTECH · FDA rejects Capricor's therapy for Duchenne again
The FDA rejected Capricor's deramiocel for Duchenne muscular dystrophy for a second time, citing serious data integrity problems in its trial.
Read the full story →
#Biotech #CapricorTherapeutics #TheDailyFathom
BIOTECH · FDA rejects Capricor's therapy for Duchenne again The FDA rejected Capricor's deramiocel for Duchenne muscular dystrophy for a second time, citing serious data integrity problems in its trial. Read the full story → #Biotech #CapricorTherapeutics #TheDailyFathom
0 vue
Publié le 21/11/2026 14:26
0:26
BIOTECH · FDA rejects Capricor's therapy for Duchenne again
The FDA rejected Capricor's deramiocel for Duchenne muscular dystrophy for a second time, citing serious data integrity problems in its trial.
Read the full story →
#Biotech #CapricorTherapeutics #TheDailyFathom
0 commentaire
?